These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4140362)

  • 21. New trends of dialysis therapy from the 1990s to the 21st century.
    Sugino N; Sanaka T; Mineshima M
    Contrib Nephrol; 1990; 82():107-11. PubMed ID: 2093521
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombogenicity of artificial organs.
    Blockmans D; Vermylen J
    Int J Artif Organs; 1990 Nov; 13(11):723-8. PubMed ID: 2089010
    [No Abstract]   [Full Text] [Related]  

  • 23. Nondialyzable toxic factor in uraemic blood effectively removed by the activated charcoal.
    Yatzidis H; Psimenos G; Mayopoulou-Symvoulidis D
    Experientia; 1969 Nov; 25(11):1144-5. PubMed ID: 5357814
    [No Abstract]   [Full Text] [Related]  

  • 24. Artificial organs 2014: a year in review.
    Malchesky PS
    Artif Organs; 2015 Mar; 39(3):260-87. PubMed ID: 25788211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of hemodialyzers and dialysis membranes. Report of a study group for the Artificial Kidney-Chronic Uremia Program NIAMDD-1977. Chapter five. Evaluation of toxicity potential of hemodialyzers.
    Klein E; Autian J; Bower JD; Buffaloe G; Centella LJ; Colton CK; Darby TD; Farrell PC; Holland FF; Kennedy RS; Lipps B; Mason R; Nolph KD; Villarroel F; Wathen RL
    Artif Organs; 1978 Aug; 2(3):284-92. PubMed ID: 708292
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the injurious nature of some materials used in the construction of artificial organs and on their cleaning with proteolytic enzymes].
    FLEISCH A; FREI PC
    Vox Sang; 1961 Jul; 6():489-97. PubMed ID: 13893482
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of artificial kidney dialysate with cycling adsorber-desorbers.
    Yoshida F; Okazaki M
    Ann Biomed Eng; 1974 Dec; 2(4):327-34. PubMed ID: 4458563
    [No Abstract]   [Full Text] [Related]  

  • 28. PRESENT STATUS OF ARTIFICIAL INTERNAL ORGANS.
    KOLFF WJ
    Ann N Y Acad Sci; 1964 Nov; 120():535-9. PubMed ID: 14235271
    [No Abstract]   [Full Text] [Related]  

  • 29. Biocompatibility--a system approach.
    Klinkmann H; Falkenhagen D
    Adv Exp Med Biol; 1989; 260():39-52. PubMed ID: 2696370
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatic failure and development of artificial liver support system.
    Williams R
    Prog Liver Dis; 1976; 5():418-35. PubMed ID: 775549
    [No Abstract]   [Full Text] [Related]  

  • 31. Presidential address.
    Leonard EF
    Trans Am Soc Artif Intern Organs; 1973; 19():634-7. PubMed ID: 4722778
    [No Abstract]   [Full Text] [Related]  

  • 32. [Artificial liver: liver-supporting systems].
    Schmidt FW
    Verh Dtsch Ges Inn Med; 1981; 87():1432-9. PubMed ID: 7331437
    [No Abstract]   [Full Text] [Related]  

  • 33. Artificial organs and biomaterials.
    Courtney JM
    J Med Eng Technol; 1993; 17(5):188-90; discussion 197-8. PubMed ID: 8151661
    [No Abstract]   [Full Text] [Related]  

  • 34. [CHOICE BETWEEN EXTRA-RENAL PURIFICATION METHODS. ARTIFICIAL KIDNEY OR PERITONEAL DIALYSIS].
    LEGRAIN M; CHAPMAN A
    Therapie; 1964; 19():1451-60. PubMed ID: 14242717
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum angiotensin-converting enzyme during haemodialysis: effect of membrane biocompatibility.
    Maher ER; Bird R; Kyle P; Curtis JR
    Nephron; 1987; 45(4):328. PubMed ID: 3035394
    [No Abstract]   [Full Text] [Related]  

  • 36. Journal of Artificial Organs 2006: the year in review.
    ; Sawa Y; Horiuchi T; Kishida A; Masuzawa T; Nishimura M; Tatsumi E; Tomizawa Y; Watanabe H
    J Artif Organs; 2007; 10(2):53-9. PubMed ID: 17574506
    [No Abstract]   [Full Text] [Related]  

  • 37. The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organs.
    Oka T
    ASAIO Trans; 1989; 35(4):778-83. PubMed ID: 2611046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to an "artificial liver".
    Brunner G
    Acta Hepatogastroenterol (Stuttg); 1978 Feb; 25(1):77-86. PubMed ID: 636747
    [No Abstract]   [Full Text] [Related]  

  • 39. Optimal perfusion-rate in haemodialysis combined with ultrafiltration.
    TWISS EE; PAULSSEN MM
    Lancet; 1960 Nov; 2(7159):1055-6. PubMed ID: 13778843
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.